comparing-effects-electronic-cigarette-vapor-cigarette-smoke-novel

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel <em>In Vivo</em> Exposure System

Electronic cigarettes (E-cigarettes) are being widely used, and growing in popularity. It is estimated that more than 9 million adults use them regularly. ...

University of Michigan Medical School

Warfarin is the current standard for oral anticoagulation therapy in patients with mechanical heart valves, yet optimal therapy to maximize anticoagulation and minimize bleeding complications requires routine coagulation monitoring, possible dietary restrictions, and drug interaction monitoring. As alternatives to warfarin, oral direct acting factor Xa inhibitors are currently approved for the prophylaxis and treatment of venous thromboembolism and reduction of stroke and systemic embolization. However, no in vivo preclinical or clinical studies have been performed directly comparing oral factor Xa inhibitors such as apixaban to warfarin, the current standard of therapy.

Angela Mathues

Jobst Vascular Research Laboratory

University of Michigan Medical School

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Angela Mathues

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Jobst Vascular Research Laboratory

University of Michigan Medical School

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Jobst Vascular Research Laboratory